Similar articles for PMID: 26199308

Year	Number of Results
2004	1
2006	4
2007	1
2009	7
2010	4
2011	9
2012	14
2013	20
2014	15
2015	20
2016	21
2017	16
2018	13
2019	5
2020	7
2021	5
2022	4
2023	3
2024	0

1

Glycemia Lowering and Risk for Heart Failure: Recent Evidence from Studies of Dipeptidyl Peptidase Inhibition.

Zhong J, Goud A, Rajagopalan S. Zhong J, et al. Circ Heart Fail. 2015 Jul;8(4):819-25. doi: 10.1161/CIRCHEARTFAILURE.114.001967. Circ Heart Fail. 2015. PMID: 26199308 Review. No abstract available.

2

Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Koska J, Sands M, Burciu C, Reaven P. Koska J, et al. Diab Vasc Dis Res. 2015 May;12(3):154-63. doi: 10.1177/1479164114562411. Epub 2015 Feb 12. Diab Vasc Dis Res. 2015. PMID: 25852133 Free article. Review.

3

Glucagon and heart in type 2 diabetes: new perspectives.

Ceriello A, Genovese S, Mannucci E, Gronda E. Ceriello A, et al. Cardiovasc Diabetol. 2016 Aug 27;15(1):123. doi: 10.1186/s12933-016-0440-3. Cardiovasc Diabetol. 2016. PMID: 27568179 Free PMC article. Review.

4

Saxagliptin, alone or in combination. No fewer complications; more cases of heart failure?

[No authors listed] [No authors listed] Prescrire Int. 2014 Sep;23(152):207. Prescrire Int. 2014. PMID: 25325118

5

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

Raschi E, Poluzzi E, Koci A, Antonazzo IC, Marchesini G, De Ponti F. Raschi E, et al. Nutr Metab Cardiovasc Dis. 2016 May;26(5):380-6. doi: 10.1016/j.numecd.2016.02.006. Epub 2016 Feb 19. Nutr Metab Cardiovasc Dis. 2016. PMID: 27067162

6

Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.

Mulvihill EE. Mulvihill EE. Peptides. 2018 Feb;100:158-164. doi: 10.1016/j.peptides.2017.11.023. Peptides. 2018. PMID: 29412815 Review.

7

Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.

Penno G, Garofolo M, Del Prato S. Penno G, et al. Nutr Metab Cardiovasc Dis. 2016 May;26(5):361-73. doi: 10.1016/j.numecd.2016.01.001. Epub 2016 Jan 13. Nutr Metab Cardiovasc Dis. 2016. PMID: 27105869 Review.

8

Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).

Thornberry NA, Gallwitz B. Thornberry NA, et al. Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):479-86. doi: 10.1016/j.beem.2009.03.004. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19748065

9

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.

Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA. Singh S, et al. Eur J Pharmacol. 2011 Feb 10;652(1-3):157-63. doi: 10.1016/j.ejphar.2010.06.001. Epub 2010 Jun 9. Eur J Pharmacol. 2011. PMID: 20540938

10

Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation.

Lim SW, Jin JZ, Jin L, Jin J, Li C. Lim SW, et al. Korean J Intern Med. 2015 Nov;30(6):759-70. doi: 10.3904/kjim.2015.30.6.759. Epub 2015 Oct 30. Korean J Intern Med. 2015. PMID: 26552451 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year